EUVIMEDOpdag EUVIMED
Crossref

Nesfatin‐1 Reduces Cholic Acid‐Induced Intrahepatic Cholestasis of Pregnancy by Regulating the General Control Nonderepressible 2/Eukaryotic Initiation Factor 2α Pathway

Yong Liang, Xiaomin Wen, Zhe Sun, Yuqiong Meng, Shuhan Lv iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70147 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2025. Written by Yong Liang and 4 co-authors. Institution: Department of Obstetrics, The First Affiliated Hospital of Guizhou University of Chinese Medicine, Guiyang, China. Major MEDLINE topics: Cholestasis, Intrahepatic, Cholic Acid, Pregnancy Complications, Eukaryotic Initiation Factor-2. 38 references. Funded by: the Project for the Construction of Inheritance Workshops of Famous Traditional Chinese Medicine Practitioners in Guizhou, Guizhou University of Traditional Chinese Medicine 2024 Youth Sail Plan Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that significantly impacts pregnancy outcomes, with oxidative stress (OS) playing a crucial role in its pathogenesis. The animal model was constructed using 8–10‐week‐old CD‐1 mice, which were administered cholic acid (CA) orally from gestational day (GD) 12–GD17 to induce placental injury. Nesfatin‐1 (NF‐1) was administered intraperitoneally to assess its protective effects. Our study found that NF‐1 effectively attenuated placental dysfunction by reducing glucocorticoid (GC) production and boosting 11β‐hydroxysteroid dehydrogenase type 2 (11β‐HSD2) expression, a key enzyme for GC inactivation. Furthermore, NF‐1 reduced OS markers such as malondialdehyde (MDA) and reactive oxygen species (ROS) in both placental tissue and HTR8/SVneo cells. The protective effects of NF‐1 were correlated with the suppression of the general control nonderepressible 2 (GCN2)/eukaryotic initiation factor 2α (eIF2α) signaling pathway, which became activated under OS conditions. Notably, halofuginone, a GCN2 agonist, abolished the beneficial effects of NF‐1, further confirming the involvement of the GCN2/eIF2α pathway. These results suggest that NF‐1 may serve as a potential therapeutic agent for managing ICP and related stress‐induced pregnancy complications by modulating GC metabolism and mitigating OS.

Subjects

MeSH terms (MEDLINE)

Cholestasis, IntrahepaticCholic AcidPregnancy ComplicationsEukaryotic Initiation Factor-2Calcium-Binding ProteinsFemalePregnancyAnimalsMiceNucleobindinsSignal TransductionOxidative StressHumansPlacentaDisease Models, AnimalReactive Oxygen SpeciesCell Line

Author keywords

11β‐HSD2GCN2/eIF2α pathwayglucocorticoidsintrahepatic cholestasis of pregnancynesfatin‐1oxidative stress

Substances

NucleobindinsCholic AcidEukaryotic Initiation Factor-2Reactive Oxygen SpeciesCalcium-Binding Proteins

Authors and institutions

  • Department of Obstetrics, The First Affiliated Hospital of Guizhou University of Chinese Medicine, Guiyang, China.

ORCID profiles: Shuhan Lv

Funding

  • the Project for the Construction of Inheritance Workshops of Famous Traditional Chinese Medicine Practitioners in Guizhou
  • Guizhou University of Traditional Chinese Medicine 2024 Youth Sail Plan Project

Cite

APA

Liang, Y., Wen, X., Sun, Z., Meng, Y., & Lv, S. (2025). Nesfatin‐1 Reduces Cholic Acid‐Induced Intrahepatic Cholestasis of Pregnancy by Regulating the General Control Nonderepressible 2/Eukaryotic Initiation Factor 2α Pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70147

Vancouver

Liang Y, Wen X, Sun Z, Meng Y, Lv S. Nesfatin‐1 Reduces Cholic Acid‐Induced Intrahepatic Cholestasis of Pregnancy by Regulating the General Control Nonderepressible 2/Eukaryotic Initiation Factor 2α Pathway. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70147

BibTeX
@article{Liang2025,
  author = {Liang, Yong and Wen, Xiaomin and Sun, Zhe and Meng, Yuqiong and Lv, Shuhan},
  title = {Nesfatin‐1 Reduces Cholic Acid‐Induced Intrahepatic Cholestasis of Pregnancy by Regulating the General Control Nonderepressible 2/Eukaryotic Initiation Factor 2α Pathway},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70147}
}
Start for free →